Environmental exposure of primary care personnel to ribavirin aerosol when supervising treatment of infants with respiratory syncytial virus infections.

AUTOR(ES)

Rodriguez, W J

RESUMO

The potential exposure to ribavirin aerosol in the environment was assessed in nurses caring for infants and children with severe lower respiratory tract infections due to respiratory syncytial virus. Ribavirin aerosol was administered via a ventilator, oxygen tent, or oxygen hood. Participants worked directly with infants receiving ribavirin for 20.0 to 35.0 h over a 3-day period. No toxic or adverse effects of ribavirin aerosol were observed in any of the 19 nurses studied, and ribavirin was not detected in erythrocytes, plasma, or urine collected after the potential exposure period.

Documentos Relacionados

• Exposure of health care workers to ribavirin during therapy for respiratory syncytial virus infections.
• Safety and pharmacokinetics of vitamin A therapy for infants with respiratory syncytial virus infections.
• Hyperimmune globulins in prevention and treatment of respiratory syncytial virus infections.
• Pediatrics: Ribavirin and Respiratory Syncytial Virus Infections
• Intravenous immunoglobulin treatment of respiratory syncytial virus infections in infants and young children.